NCT00045318View on ClinicalTrials.gov

Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2002

Study Completion Date

October 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

exatecan mesylate

Trial Locations (5)

78229

Cancer Therapy and Research Center, San Antonio

St. Luke's Lutheran Hospital, San Antonio

78234

Brooke Army Medical Center, Fort Sam Houston

78284

Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio

90095

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00045318 - Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction | Biotech Hunter | Biotech Hunter